Antonella Castagna

21.2k total citations · 1 hit paper
340 papers, 5.7k citations indexed

About

Antonella Castagna is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Antonella Castagna has authored 340 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 228 papers in Infectious Diseases, 191 papers in Virology and 95 papers in Epidemiology. Recurrent topics in Antonella Castagna's work include HIV Research and Treatment (178 papers), HIV/AIDS drug development and treatment (167 papers) and HIV/AIDS Research and Interventions (113 papers). Antonella Castagna is often cited by papers focused on HIV Research and Treatment (178 papers), HIV/AIDS drug development and treatment (167 papers) and HIV/AIDS Research and Interventions (113 papers). Antonella Castagna collaborates with scholars based in Italy, United States and United Kingdom. Antonella Castagna's co-authors include Adriano Lazzarin, Antonella d’Arminio Monforte, Laura Galli, Nicola Gianotti, Vincenzo Spagnuolo, Paola Cinque, Andrea Antinori, Luca Vago, Marco Ripa and Massimo Clementi and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Antonella Castagna

309 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

2022 164 citations Antonella Castagna et al. profile →

Peers

Countries citing papers authored by Antonella Castagna

Since Specialization

Citations

This map shows the geographic impact of Antonella Castagna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonella Castagna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonella Castagna more than expected).

Fields of papers citing papers by Antonella Castagna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonella Castagna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonella Castagna. The network helps show where Antonella Castagna may publish in the future.

Co-authorship network of co-authors of Antonella Castagna

This figure shows the co-authorship network connecting the top 25 collaborators of Antonella Castagna. A scholar is included among the top collaborators of Antonella Castagna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonella Castagna. Antonella Castagna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Routine HIV RNA Testing During Injectable Cabotegravir and Oral Preexposure Prophylaxis Use 2025 ·Clinical Infectious Diseases ·Angelo Roberto Raccagni, (unknown), Elena Bruzzesi, Camilla Muccini, Antonella Castagna, Silvia Nozza	0
2	OC-66 Socio-demographic, clinical and therapeutic features of persons with HIV (PWH) currently in care in Italy: data from the ICONA cohort 2024 ·Antonella d’Arminio Monforte, (unknown), Iuri Fanti, Carlo Federico Perno, Daniela Segala, Antonella Santoro, (unknown), Leonardo Calza, Anna Carraro, Antonella Cingolani, Massimo Puoti, Antonella Castagna, Sergio Lo Caputo, (unknown), Andrea Antinori	0
3	Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors 2024 ·BMJ Open ·(unknown), Laura Galli, (unknown), Roberta Gagliardini, Filippo Lagi, Sergio Ferrara, Anna Maria Cattelan, Emanuele Focà, Antonio Di Biagio, (unknown), Leonardo Calza, Franco Maggiolo, Giulia Marchetti, Giovanni Cenderello, Stefano Rusconi, Maurizio Zazzi, Maria Mercedes Santoro, Vincenzo Spagnuolo, Antonella Castagna	6
4	Trends of Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates Between 2012 and 2023: Results From an Open Italian Cohort 2024 ·Sexually Transmitted Diseases ·(unknown), Angelo Roberto Raccagni, Laura Galli, (unknown), Martina Ranzenigo, Marco Ripa, (unknown), (unknown), Floriana Gona, Nicola Clementi, Roberto Burioni, Silvia Carletti, Antonella Castagna, Silvia Nozza	4
5	Mpox Virus: Control of In-Hospital Occupational Transmission Experience from a Tertiary Level Hospital in Milan, Italy 2023 ·Life ·Angelo Roberto Raccagni, Nicola Gianotti, Matteo Moro, Davide Mileto, (unknown), Antonella Castagna, Silvia Nozza	3
6	Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice 2023 ·Drug Design Development and Therapy ·Diana Canetti, Laura Galli, (unknown), Silvia Nozza, Vincenzo Spagnuolo, Camilla Muccini, (unknown), Elena Bruzzesi, Martina Ranzenigo, Matteo Chiurlo, Antonella Castagna, Nicola Gianotti	2
7	Is SARS‐CoV‐2‐induced disease a decisive factor influencing testosterone in males? Findings from a case‐control ex post facto study 2023 ·Andrology ·Paolo Capogrosso, (unknown), Marina Pontillo, Anna Maria Ferrara, (unknown), Cristina Carenzi, Giuseppe A. Ramirez, Cristina Tresoldi, Massimo Locatelli, Antonella Castagna, Francesco De Cobelli, Moreno Tresoldi, Alberto Zangrillo, Giovanni Landoni, Patrizia Rovere‐Querini, Fabio Ciceri, Francesco Montorsi, Giacomo Monti, Andrea Salonia	1
8	PRESTIGIO RING: "An 80-year-old man living with HIV resistant to all four antiretroviral classes and desiring treatment simplification" 2023 ·Cineca Institutional Research Information System (Tor Vergata University) ·Maria Mazzitelli, Maurizio Zazzi, (unknown), Vincenzo Spagnuolo, Maria Mercedes Santoro, Emanuele Focà, Anna Maria Cattelan, Antonella Castagna	1
9	Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study 2023 ·Journal of Antimicrobial Chemotherapy ·Ili Margalit, Giusy Tiseo, Marco Ripa, Vanni Borghi, (unknown), Virginie Prendki, Niccolò Riccardi, Giovanni Battista Perego, Alessandro Grembiale, Laura Galli, (unknown), Antonella Castagna, Cristina Mussini, Marco Falcone, Dafna Yahav	5
10	Mpox Outbreak 2022: A Comparative Analysis of the Characteristics of Individuals Receiving MVA-BN Vaccination and People Diagnosed with Mpox Infection in Milan, Italy 2023 ·Pathogens ·(unknown), Angelo Roberto Raccagni, (unknown), (unknown), Elena Bruzzesi, Caterina Candela, (unknown), (unknown), (unknown), Antonella Castagna, Silvia Nozza	2
11	Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 2023 ·Microorganisms ·Giuseppe A. Ramirez, Marco Ripa, Samuele E. Burastero, (unknown), Diego Bagnasco, (unknown), (unknown), (unknown), (unknown), (unknown), Antonella Castagna, Lorenzo Dagna, Mona‐Rita Yacoub	22
12	Efficacy and Safety Profile of Fostemsavir for the Treatment of People with Human Immunodeficiency Virus-1 (HIV-1): Current Evidence and Place in Therapy 2022 ·SHILAP Revista de lepidopterología ·Camilla Muccini, Diana Canetti, Antonella Castagna, Vincenzo Spagnuolo	19
13	Impact of Remdesivir on SARS-CoV-2 Clearance in a Real-Life Setting: A Matched-Cohort Study 2022 ·Drug Design Development and Therapy ·Vincenzo Spagnuolo, (unknown), (unknown), Laura Galli, Andrea Poli, Elena Bruzzesi, (unknown), Nicola Clementi, (unknown), Moreno Tresoldi, Patrizia Rovere‐Querini, Lorenzo Dagna, Alberto Zangrillo, Fabio Ciceri, Massimo Clementi, Antonella Castagna	3
14	Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database 2020 ·International Journal of Antimicrobial Agents ·Francesca Lombardi, Andrea Giacomelli, Daniele Armenia, Alessia Lai, (unknown), (unknown), (unknown), Francesco Saladini, Francesca Vichi, Paola Corsi, (unknown), Bianca Bruzzone, Roberta Gagliardini, Annapaola Callegaro, Antonella Castagna, Maria Mercedes Santoro	15
15	In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients 2020 ·Journal of Antimicrobial Chemotherapy ·Francesco Saladini, (unknown), (unknown), Franco Maggiolo, Francesca Vichi, Giulio Maria Corbelli, Andrea Galli, Alba Bigoloni, (unknown), Maria Mercedes Santoro, Maurizio Zazzi, Antonella Castagna	11
16	Glomerular filtration rate estimated by cystatin C formulas in HIV-1 patients treated with dolutegravir, rilpivirine or cobicistat. 2018 ·PubMed ·(unknown), Laura Galli, Andrea Poli, Vincenzo Spagnuolo, Antonella Castagna, Nicola Gianotti	9
17	Evolution of major non‐HIV‐related comorbidities in HIV‐infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 2018 ·HIV Medicine ·Antonella d’Arminio Monforte, Helena Díaz-Cuervo, Andrea De Luca, Franco Maggiolo, Antonella Cingolani, Stefano Bonora, Antonella Castagna, Enrico Girardi, Andrea Antinori, Sergio Lo Caputo, Giovanni Guaraldi, Alessandro Cozzi‐Lepri	23
18	Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience 2010 ·AIDS ·Silvia Nozza, Laura Galli, (unknown), Alessandro Soria, Filippo Canducci, Stefania Salpietro, Nicola Gianotti, Alba Bigoloni, Liviana Della Torre, Giuseppe Tambussi, Adriano Lazzarin, Antonella Castagna	37
19	Treatment complexity and risk of virological rebound in persons receiving cART 2007 ·UCL Discovery (University College London) ·Adriana Ammassari, Alessandro Cozzi‐Lepri, (unknown), (unknown), Carlo Torti, Antonella Castagna, Andrea De Luca, (unknown), Andrea Antinori, (unknown)	2
20	The introduction of the fusion inhibitors in the HAART-regimens. 2004 ·Università Politecnica delle Marche (Università Politecnica delle Marche) ·Hamid Hasson, Antonella Castagna, Massimo Clementi, Anna Danise, Adriano Lazzarin, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact